Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1) )
Product Specifications
CAS Number
1238217-55-4
Synonyms
GBR500
Target
Integrin
Applications
Cytoskeletal Signaling
Additionnal Information
Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1) ) is a monoclonal antibody targeting the α2 subunit (CD49b) of very late antigen-2 (VLA-2) . It can be used for the research of multiple sclerosis. MW: 144.56 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040669-100 1x 100 µL
P27 / KIP1 (SX53G8), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040040-500 1x 500 µL
CD35 / CR1 (E11), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470633-500 1x 500 µL
Von Willebrand Factor (3E2D10), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740253-100 1x 100 µL
Cytokeratin, LMW (AE-1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 